CBC Health Services Pioneers Erectile Dysfunction Care in Central African Sub-region
Bamenda, Cameroon – The Cameroon Baptist Convention (CBC) Health Services in its holistic drive of rendering compassionate care to all in need, has added yet another service to the avalanche of medical services she has been rendering for over five decades and counting now.
The new service – erectile dysfunction care, is a novelty in Cameroon and the Central African Sub-region. The service began receiving patients [men] with erectile dysfunction following the acquisition and installation of a machine to handle such issues. Hosted at Nkwen Baptist Hospital, the machine – ED 100 will “will use the shockwave technology to create new blood vessels around the penile shaft to produce and sustain an erection,” says Dr. Oluranti Adekunle, Sex Therapist and CEO of Mediaspec, Nigeria.
According to Dr. Adekunle, erectile dysfunction treatment will involve 12 sessions of the administration of shockwave therapy. Shockwave therapy is painless and requires no anaesthesia, no side effects, and no injection. “On or before the twelfth session the patient will be able to sustain an erection,” emphasized the Sex Therapist.
Though statistics on the prevalence of people with erectile dysfunctions are scarce to come by, Dr. Adekunle says repeated studies elsewhere indicate that “50% of mature men” have erectile issues.
Prof. Tih Pius Muffih, Director of CBC Health Services, speaking during the launching of the machine on December 16, 2002, said the erectile dysfunction machine will be “A solution to the cases [they’ve] had come in from time to time in hospitals of CBC Health Services.”
Despite being a great response to erectile issues, whose root causes are mostly vasculogenic, Prof. Tih called on women to watch out for psychological issues that hamper men’s [their husbands] erections and sex drive and not blame it for an erectile dysfunction.
ED 100 is a Medipec’s pioneered technology that came into the market in 2010 and thus far the first and only therapy that addresses the causes of vasculogenic erectile dysfunction.